LakeShore Biopharma Co., Ltd (LSB)
NASDAQ: LSB · Real-Time Price · USD
2.620
+0.130 (5.22%)
Nov 20, 2024, 4:00 PM EST - Market closed
LakeShore Biopharma Market Cap
LakeShore Biopharma has a market cap or net worth of $49.99 million as of November 21, 2024. Its market cap has increased by 9.63% in one year.
Market Cap
49.99M
Enterprise Value
74.66M
1-Year Change
9.63%
Ranking
Category
Stock Price
Market Cap Chart
Since August 5, 2021, LakeShore Biopharma's market cap has decreased from $227.76M to $49.99M, a decrease of -78.05%. That is a compound annual growth rate of -36.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 47.51M | -0.09% |
| Dec 29, 2023 | 47.55M | -80.26% |
| Dec 30, 2022 | 240.85M | 3.14% |
| Dec 29, 2021 | 233.52M | 2.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CollPlant Biotechnologies | 47.54M |
| Unicycive Therapeutics | 47.24M |
| Burning Rock Biotech | 47.09M |
| HCW Biologics | 46.90M |
| Immix Biopharma | 46.49M |
| Apyx Medical | 46.30M |
| SHL Telemedicine | 45.89M |
| CalciMedica | 45.53M |